Showing 451-460 of 560 results for "".
Prurigo Nodularis: An Update for Clinicians, Part 1
https://practicaldermatology.com/topics/general-topics/prurigo-nodularis-an-update-for-clinicians-part-1/20507/Here's a look at the diagnosis of an “eczematous” condition with an unclear etiology.Reversing Cicatricial Ectropion Related to Chronic Periocular Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/reversing-cicatricial-ectropion-related-to-chronic-periocular-atopic-dermatitis/23752/Clinical Insights and Emerging Therapeutic Options for Chronic Hand Eczema
https://practicaldermatology.com/issues/october-2025/clinical-insights-and-emerging-therapeutic-options-for-chronic-hand-eczema/39763/Chronic hand eczema (CHE) represents a significant clinical challenge in dermatology practice, affecting approximately 5% of the population—a prevalence approximately twice that of psoriasis.Notable Case Report: Intralesional Kenalog Injections for Chemotherapy-Induced Alopecia; Ask An Expert: Hair Loss
https://practicaldermatology.com/youngmd-connect/resident-resource-center/notable-case-report-intralesional-kenalog-injections-for-chemotherapy-induced-alopecia-ask-an-expert-hair-loss/21052/Is Bone Mineral Density Testing Indicated with Long-Term IM Triamcinolone Acetonide Therapy?
https://practicaldermatology.com/topics/general-topics/PD1208_05-php/22603/Prospective data are lacking, but early findings suggest little if any risk of density-loss among patients on long-term therapy.News
https://practicaldermatology.com/topics/practice-management/news/21156/Natural Products that Exhibit Antifungal Activity
https://practicaldermatology.com/topics/general-topics/natural-products-that-exhibit-antifungal-activity/20360/Can natural products fight the fungus among us?The State of Prevention in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/the-state-of-prevention-in-atopic-dermatitis/23183/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-33/23690/Selecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.